| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.178 | 7.259 | 7.246 | 11.295 | 9.588 | 8.828 | 6.469 | 2.778 | 0 | 13.819 |
| Total Income - EUR | 9.178 | 7.259 | 7.246 | 11.295 | 9.588 | 8.828 | 6.469 | 2.778 | 0 | 13.819 |
| Total Expenses - EUR | 10.443 | 6.419 | 7.257 | 11.280 | 9.447 | 8.658 | 6.813 | 2.513 | 0 | 12.530 |
| Gross Profit/Loss - EUR | -1.265 | 840 | -11 | 15 | 141 | 170 | -344 | 265 | 0 | 1.289 |
| Net Profit/Loss - EUR | -1.540 | 768 | -83 | -98 | 45 | 82 | -409 | 237 | 0 | 1.083 |
| Employees | 4 | 3 | 3 | 3 | 3 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Nurivalon Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 101 | 850 | 433 | 1.924 | 3.559 | 691 | 2.650 | 3.721 | 3.709 | 4.201 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 892 |
| Receivables | 25 | 14 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 76 | 837 | 427 | 1.924 | 3.559 | 691 | 2.650 | 3.721 | 3.709 | 3.308 |
| Shareholders Funds | -1.801 | -1.015 | -1.081 | -1.160 | 87 | -990 | -1.377 | -1.144 | -1.140 | -51 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.901 | 1.866 | 1.515 | 3.083 | 3.472 | 1.681 | 4.027 | 4.864 | 4.849 | 4.252 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1071 - 1071" | |||||||||
| CAEN Financial Year |
1071
|
|||||||||
Comments - Nurivalon Srl